[Other] Second-Line Ponatinib in Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients Failing or Intolerant to First-Line Second Generation Tyrosine Kinase Inhibitor (TKI) Treatment: An Interim Analysis of the Prospective PONS Trial |
|
This post will be closed automatically in 2026-08-23 02:08
Reward56points
|
20
The Thorny History of the Holotype of Rinelepis histrix Valenciennes, 1840 (Siluriformes: Loricariidae), an Eighteenth-Century Naturalist Relic
20
Composition-Controlled Band Alignment and Cl-Mediated Surface Stabilization of ZnSeTe Quantum Dots for Efficient and Stable QLEDs
20
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
20
Belgian military spending: A narrative of decline, stagnation, and recent reversal
20
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
